Nova Leah develop expert cybersecurity risk assessment solutions specific for connected medical devices.
Nova Leah believe in excellence through knowledge development, sharing and collaboration to enhance the security assurance of medical devices. Nova Leah's product, SelectEvidence, is an intelligent cybersecurity risk management compliance solution aimed at medical device manufacturers and healthcare providers.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 7, 2021 | Series Unknown | — | 3 | Northwell Ventures | — | Detail |
Mar 4, 2019 | Series Unknown | €3.70M | — | — | — | Detail |
Nov 8, 2018 | Series Unknown | €2.25M | 3 | Kernel Capital | — | Detail |
Oct 12, 2017 | Series Unknown | €500K | 2 | COSIMO Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Northwell Ventures | Yes | Series Unknown |
COSIMO Ventures | Yes | Series Unknown |
Kernel Capital | — | Series Unknown |
Sure Valley Ventures | — | Series Unknown |
Enterprise Ireland | — | Series Unknown |